The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials.
Warner CV, Syc SB, Stankiewicz AM, Hiremath G, Farrell SK, Crainiceanu CM, Conger A, Frohman TC, Bisker ER, Balcer LJ, Frohman EM, Calabresi PA, Saidha S.
Warner CV, et al. Among authors: hiremath g.
PLoS One. 2011;6(8):e22947. doi: 10.1371/journal.pone.0022947. Epub 2011 Aug 11.
PLoS One. 2011.
PMID: 21853058
Free PMC article.
Clinical Trial.